Instrumento Inactivo

Acciones MAP Pharmaceuticals Inc.

Acciones

Precio de cierre Nasdaq Otros sitios de cotización
- ^USD	-

MAP Pharmaceuticals Inc. : Law Office of Brodsky & Smith, LLC Announces Investigation of MAP Pharmaceuticals, Inc.	26/01/13
MAP Pharmaceuticals Inc. : Ryan & Maniskas, LLP Announces Investigation of MAP Pharmaceuticals, Inc.	24/01/13
MAP Pharmaceuticals Inc. : Law Office of Brodsky & Smith, LLC Announces Investigation of MAP Pharmaceuticals, Inc.	24/01/13
MAP Pharmaceuticals Inc. : INVESTOR ALERT: Brannon Law Firm, L.L.C. is Investigating the Proposed Tender Offer/Merger of MAP Pharmaceuticals, Inc. by Allergan, Inc.	23/01/13
MAP Pharmaceuticals Inc. : Law Firm Brower Piven Announces Investigation of MAP Pharmaceuticals, Inc.	23/01/13

Sector

	Varia. 1 de ene.	Capi.
VERTEX PHARMACEUTICALS INCORPORATED	+9,58 %	115 mil M
REGENERON PHARMACEUTICALS, INC.	+12,41 %	107 mil M
ARGENX SE	-2,59 %	21,6 mil M
BIONTECH SE	-12,38 %	22,31 mil M
GENMAB A/S	-5,29 %	19,19 mil M
BEIGENE, LTD.	-3,35 %	18,23 mil M
WUXI APPTEC CO., LTD.	-38,57 %	17,62 mil M
NEUROCRINE BIOSCIENCES, INC.	+7,51 %	14,26 mil M
SAREPTA THERAPEUTICS, INC.	+35,67 %	12,37 mil M